| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
108.15(B) |
| Last
Volume: |
4,786,595 |
Avg
Vol: |
8,429,684 |
| 52
Week Range: |
$48.64 - $75.67 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
250,541 |
430,874 |
929,865 |
2,041,378 |
| Total Sell Value |
$18,359,902 |
$29,055,549 |
$55,374,067 |
$104,875,147 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
14 |
25 |
42 |
77 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Phalen Michael P. |
SVP & President, Endoscopy |
• – – |
2010-07-01 |
4 |
D |
$5.90 |
$4,932 |
D/D |
(836) |
28,366 |
|
- |
|
| Phalen Michael P. |
SVP & President, Endoscopy |
• – – |
2010-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,630 |
29,202 |
|
- |
|
| Pucel Kenneth |
EVP, Global Operations |
• – – |
2010-07-01 |
4 |
D |
$5.90 |
$14,986 |
D/D |
(2,540) |
67,000 |
|
- |
|
| Pucel Kenneth |
EVP, Global Operations |
• – – |
2010-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
69,540 |
|
- |
|
| Moreci Stephen F |
SVP, Global Sales Operations |
• – – |
2010-07-01 |
4 |
D |
$5.90 |
$14,986 |
D/D |
(2,540) |
26,637 |
|
- |
|
| Moreci Stephen F |
SVP, Global Sales Operations |
• – – |
2010-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
29,177 |
|
- |
|
| Pedersen John B. |
Pres,Uro & Womens Health |
• – – |
2010-07-01 |
4 |
D |
$5.90 |
$5,658 |
D/D |
(959) |
3,502 |
|
- |
|
| Pedersen John B. |
Pres,Uro & Womens Health |
• – – |
2010-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,020 |
4,461 |
|
- |
|
| Kucheman William |
EVP, Cardiology |
• – – |
2010-07-01 |
4 |
D |
$5.90 |
$8,059 |
D/D |
(1,366) |
47,355 |
|
- |
|
| Kucheman William |
EVP, Cardiology |
• – – |
2010-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,300 |
48,721 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-07-01 |
4 |
AS |
$5.82 |
$145,380 |
I/I |
(25,000) |
8,181,021 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-07-01 |
4 |
AS |
$5.82 |
$436,535 |
I/I |
(75,000) |
1,941,949 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-06-30 |
4 |
AS |
$5.85 |
$146,230 |
I/I |
(25,000) |
8,206,021 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-06-30 |
4 |
AS |
$5.84 |
$438,160 |
I/I |
(75,000) |
2,016,949 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-06-29 |
4 |
AS |
$5.87 |
$440,383 |
I/I |
(75,000) |
2,091,949 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-06-29 |
4 |
AS |
$5.88 |
$147,088 |
I/I |
(25,000) |
8,231,021 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-06-28 |
4 |
AS |
$6.08 |
$152,075 |
I/I |
(25,000) |
8,256,021 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-06-28 |
4 |
AS |
$6.07 |
$455,345 |
I/I |
(75,000) |
2,166,949 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-06-25 |
4 |
AS |
$6.00 |
$150,055 |
I/I |
(25,000) |
8,281,021 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-06-25 |
4 |
AS |
$6.00 |
$451,210 |
I/I |
(75,000) |
2,241,949 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-06-24 |
4 |
AS |
$5.99 |
$449,345 |
I/I |
(75,000) |
2,316,949 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-06-24 |
4 |
AS |
$5.99 |
$149,710 |
I/I |
(25,000) |
8,306,021 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-06-23 |
4 |
AS |
$6.00 |
$149,903 |
I/I |
(25,000) |
8,331,021 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-06-23 |
4 |
AS |
$5.99 |
$449,258 |
I/I |
(75,000) |
2,391,949 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-06-22 |
4 |
AS |
$6.12 |
$459,148 |
I/I |
(75,000) |
2,466,949 |
|
- |
|
1831 Records found
|
|
Page 38 of 74 |
|
|
1.25 (1.68%) 
